PDS Biotechnology Post-ASCO Conference Call - Corporate Analyst Meeting Transcript
Hello, and welcome to the PDS Biotechnology Post ASCO Conference Call and Webcast. (Operator Instructions) As a reminder, this conference is being recorded.
It's now my pleasure to turn the call over to Deanne Randolph, Vice President, Commercial Development. Please go ahead.
Good morning, and welcome to PDS Biotechnology's Post ASCO webcast. With me today are Dr. Frank Bedu-Addo, Chief Executive Officer; Dr. Lauren V. Wood, Chief Medical Officer; and Dr. Seth Van Voorhees, Chief Financial Officer.
Earlier this morning, PDS Biotech issued a press release summarizing the data presented yesterday afternoon at the American Society of Clinical Oncology Annual Meeting. The company's press release is available on PDS Biotech's website at pdsbiotech.com, and a recording of this webcast will be posted to the website later today and will be archived there for future reference.
Before we begin, I would like to caution listeners that comments made by
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |